Neurology as a branch of medicine is an exciting field that constantly incorporates discoveries to improve the diagnosis and treatment of neurological disorders. Driven by relentless technological innovations, the intersection of medical science and technology gives rise to a new era of solutions.
One promising approach for developing novel and reliable diagnostic tools is AI and ML, which can analyze large and diverse datasets of neuroimaging, neurophysiology, genetics, or even clinical information to address neurological diseases. For example, a recent study used a deep learning model to classify patients with Alzheimer’s, mild cognitive impairment, and normal cognition based on MRI scans, achieving a 92 percent accuracy that outperformed conventional radiological assessment.
Similarly, gene therapy is an emerging solution that offers a long-lasting and specific treatment for diseases caused by genetic mutations and dysregulation. One study’s results of a phase 1/2 trial of gene therapy for Parkinson’s disease reported the successful delivery of a gene encoding an enzyme that converts levodopa into dopamine in a patient’s striatum. This illustrates how innovation can safely and effectively reduce motor symptoms while improving quality of life.
From precision diagnostics to wearable devices and neurostimulation therapies to AI/ML, medical technology is driving a paradigm shift in maintaining brain health worldwide by unlocking the mysteries of the human brain.
The MedTech Outlook edition presents some of the most promising neurology solutions providers in 2023. This edition includes some thought leadership articles from Dr. Karl Marlowe, a Consultant Psychiatrist and Chief Medical Officer at Oxford Health NHS Foundation Trust, Michael Wong, Founder, Owner and Veterinary Neurologist at Southeast Veterinary Neurology, and Benjamin Kummer, Director of Clinical Informatics at Mount Sinai Health System. The edition also features the talented clinical-stage company that developed a personalized closed-loop neuromodulation therapy for Alzheimer’s disease.
